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Aims
Hypoxic-ischemic injury (HI) to the developing brain
remains a major cause of morbidity. Hypothermia is
currently the only established neuroprotective treatment
available for term borns with hypoxic-ischemic encepha-
lopathy, saving one in eight infants from developing
severe neurological deficits. Therefore, additional treat-
ments with clinically applicable drugs are indispensable.
Furthermore, the pathophysiological mechanisms of
hypothermia-induced recovery are not clearly understood.
This study examines a potential additive neuroprotective
effect of hypothermia combined with levetiracetam in neo-
natal mouse HI.
Methods
9-days-old C57BL/6-mice were subjected either to a sham-
operation or to HI (modified Rice-Vannucci-model). After
HI, the pups were randomized into six groups: 1) no treat-
ment, 2) hypothermia (whole body-cooling, 4 hours, 32°
C), 3) high-dose levetiracetam intraperitoneal (70 mg/kg
body weight), 4) hypothermia combined with high-dose
levetiracetam intraperitoneal, 5) low-dose levetiracetam
intraperitoneal (7 mg/kg body weight), 6) hypothermia
combined with low-dose levetiracetam intraperitoneal.
Parameters of apoptosis (cleaved Caspase-3, TUNEL) and
myelination (myelin basic protein) were analyzed 24 hours
after HI by protein analysis and immunhistochemistry.
From P28 to P60, cognitive and sensorimotor function
was assessed via different tests.
Results
Hypothermia only and combined with low-dose levetirace-
tam was associated with a decrease of apoptosis and an
increase of myelinated cells, but without additive effects.
Intraperitoneal treatment with high-dose levetiracetam
caused an increase of apoptotic factors. Behavioural testing
demonstrated improved cognitive and sensorimotor out-
come after treatment with hypothermia.
Conclusion
Whole-body cooling provides neuroprotection in the
neonatal mouse brain by reducing apoptosis and preser-
vation of myelination. However, treatment with levetira-
cetam after hypoxic-ischemic injury has no additive
effects.
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